|
시장보고서
상품코드
2069113
뎅기열 검사 시장 규모, 점유율 및 성장 분석 : 진단 기술별, 제품 유형별, 검체 유형별, 서비스 형태별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Dengue Testing Market Size, Share, and Growth Analysis, By Diagnostic Technology, By Product Type, By Sample Type, By Service Modality, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 뎅기열 검사 시장 규모는 2024년에 6억 8,906만 달러로 평가되었고, 2025년 7억 2,565만 달러에서 2033년까지 10억 9,770만 달러로 성장하여 예측 기간(2026-2033년)에 CAGR 5.31%를 기록할 전망입니다.
뎅기열 검사 시장은 도시화와 기후 변화의 영향을 크게 받고 있으며, 이러한 요인들이 인구 밀집 지역에서의 감염 확산의 한 원인이 되고 있습니다. 이러한 상황은 의료 시스템에 막대한 부담을 주고 있으며, 정부는 환자에 대한 신속한 확정 진단과 효과적인 대책을 시행하기 위해 첨단 진단 솔루션의 도입을 추진하고 있습니다. 애보트와 로슈 같은 기업들은 스마트폰 앱과 연동되는 휴대용 면역 측정 장치를 도입하고 있으며, 유행 억제를 목표로 하는 자금 지원 기관들의 관심을 끌고 있습니다. 신흥 경제국에서 가처분 소득이 증가하고 보험 적용 범위가 확대됨에 따라, 검사 기관 네트워크가 더욱 확장되어 수익 성장과 질병 감시 체계의 강화가 가능해졌습니다. 또한, 뎅기열 진단에 AI 기반 자동화 기술을 도입함으로써 검사 프로세스의 최적화, 검체 처리의 효율화 및 정확도 향상을 통해 효율성을 높이고, 이 질병과의 싸움과 신속한 대응을 보장하기 위한 필수 요소로서 최신 검사 솔루션을 자리매김하고 있습니다.
세계 뎅기열 검사 시장의 성장 요인
세계 도시 인구의 급증은 네타이시마카의 번식을 촉진하는 과밀 환경을 조성하여, 뎅기열 감염 유병률 상승으로 이어지고 있습니다. 이러한 질병 발생률 증가로 인해 의료 제공업체와 당국은 효과적인 사례 파악 및 관리를 위해 신속한 진단 조치를 취할 수밖에 없게 되었습니다. 그 결과, 신뢰성이 높은 검사 키트에 대한 수요가 증가하고 있습니다. 이러한 것들은 환자 치료의 질을 높이고 신흥 시장에서 감염 확산을 억제하는 데 기여하며, 신속하고 정확한 결과를 필요로 하는 병원, 검사 기관 및 공중보건 대책에 있어 필수적인 요소입니다. 또한, 일반 시민들의 인식이 높아짐에 따라 지역 사회가 적극적인 검사 전략을 채택하도록 장려되고 있습니다.
세계 뎅기열 검사 시장의 제약 요인
첨단 뎅기열 진단 키트의 높은 비용은 특히 뎅기열이 유행하고 예산이 제한적인 저소득 지역에서 의료 제공업체들에게 현저한 장벽이 되고 있습니다. 재정적 제약으로 인해 병원과 공중보건 기관은 비용 대비 효과를 철저히 평가할 수밖에 없으며, 그 결과 더 저렴하지만 기술적으로 열등한 검사 방법이 채택되는 경우가 빈번합니다. 이러한 가격 문제는 혁신적인 기술 시장 진입을 저해하고 수요 증가를 억제하는 한편, 제조업체들로 하여금 제품 성능 향상과 가격 인하 사이의 균형을 맞추어 제품을 더욱 이용하기 쉽게 만들도록 압박하고 있습니다. 그 결과, 이러한 상황이 뎅기열 검사 시장의 잠재적 발전을 저해하고 있습니다.
세계 뎅기열 검사 시장 동향
세계 뎅기열 검사 시장에서는 분산형 의료에 대한 수요가 증가함에 따라, 현장 진단(Point-of-Care) 검사 솔루션의 확대라는 뚜렷한 추세가 나타나고 있습니다. 이러한 변화로 인해 진료소, 학교, 지역 보건소 등 다양한 환경에서 활용할 수 있는 신속하고 휴대용 뎅기열 진단 도구에 대한 수요가 증가하고 있습니다. 각 제조업체들은 배터리 구동 플랫폼에 사용자 친화적인 인터페이스를 통합하는 움직임을 강화하고 있으며, 이를 통해 최소한의 교육만 받은 직원이라도 신속하고 신뢰할 수 있는 결과를 얻을 수 있게 되었습니다. 이러한 발전은 중앙 검사실에 대한 의존도를 낮출 뿐만 아니라, 환자의 분류 시간을 단축하고, 외딴 지역의 유행 지역에서 효과적인 집단 발생 감시를 촉진함으로써, 현장 진단 솔루션을 시장 성장의 핵심 요인으로 자리매김하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 뎅기열 검사 시장 규모 : 진단 기술별
세계의 뎅기열 검사 시장 규모 : 제품 유형별
세계의 뎅기열 검사 시장 규모 : 샘플 유형별
세계의 뎅기열 검사 시장 규모 : 서비스 형태별
세계의 뎅기열 검사 시장 규모 : 최종사용자별
세계의 뎅기열 검사 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.07.01Global Dengue Testing Market size was valued at USD 689.06 Million in 2024 and is poised to grow from USD 725.65 Million in 2025 to USD 1097.7 Million by 2033, growing at a CAGR of 5.31% during the forecast period (2026-2033).
The dengue testing market is significantly influenced by urbanization and climate change, which contribute to increased transmission in densely populated areas. This scenario places immense pressure on healthcare systems, prompting governments to embrace advanced diagnostic solutions for quicker case confirmation and effective control measures. Companies like Abbott and Roche have introduced portable immunoassay devices integrated with smartphone applications, driving interest from funding organizations aiming to mitigate outbreaks. The rise in disposable incomes and enhanced insurance coverage in emerging economies further expands laboratory networks, enabling revenue growth and better disease surveillance. Additionally, the integration of AI-driven automation in dengue diagnostics enhances efficiency by optimizing assay processes, streamlining sample handling, and improving accuracy, positioning modern testing solutions as integral in combating the disease and ensuring timely responses.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dengue Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Dengue Testing Market Segments Analysis
Global dengue testing market is segmented by diagnostic technology, product type, sample type, service modality, end-user and region. Based on diagnostic technology, the market is segmented into NS1 Antigen Tests, IgM and IgG Serology ELISA, RT-PCR Molecular Tests, Combination and Panel Assays and Novel Biosensor-Based Tests. Based on product type, the market is segmented into Rapid Diagnostic Test Kits, ELISA Kits and Reagents and PCR Molecular Assay Kits. Based on sample type, the market is segmented into Serum and Plasma, Whole Blood, Saliva and Oral Fluid and Others. Based on service modality, the market is segmented into Centralized Laboratory Testing and Point-of-Care Testing. Based on end-user, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Home Care and Self-Testing Centres, Public Health and Surveillance Agencies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Dengue Testing Market
The global surge in urban populations leads to crowded environments that are conducive to the proliferation of Aedes mosquitoes, resulting in a higher prevalence of dengue infections. This increased disease incidence compels healthcare providers and authorities to implement swift diagnostic measures for effective case identification and management. As a result, there is a growing demand for dependable testing kits, which are essential for hospitals, laboratories, and public health initiatives striving for rapid and accurate results that enhance patient care and assist in controlling outbreaks in emerging markets. Additionally, elevated public awareness encourages communities to adopt proactive testing strategies.
Restraints in the Global Dengue Testing Market
The elevated costs linked to advanced dengue diagnostic kits present a notable obstacle for healthcare providers, especially in low-income areas where dengue is prevalent and budgets are limited. Financial constraints require hospitals and public health initiatives to thoroughly assess cost-effectiveness, frequently resulting in the adoption of cheaper, less advanced testing options. This pricing challenge hampers the market entry of innovative technologies, stifles demand growth, and drives manufacturers to find a balance between enhancing performance and reducing prices to make their products more accessible. Consequently, this dynamic limits the potential advancements within the dengue testing market.
Market Trends of the Global Dengue Testing Market
The global dengue testing market is witnessing a significant trend towards the expansion of point-of-care testing solutions, driven by the growing need for decentralized healthcare. This shift has spurred demand for rapid and portable dengue diagnostic tools that can be utilized in various settings, such as clinics, schools, and community health posts. Manufacturers are increasingly integrating battery-operated platforms with user-friendly interfaces, enabling minimally trained personnel to deliver reliable results swiftly. Such advancements not only reduce dependence on central laboratories, but also enhance patient triage times and facilitate effective outbreak surveillance in remote endemic regions, establishing point-of-care solutions as a vital component of market growth.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Dengue Testing Market Size by Diagnostic Technology & CAGR (2026-2033)
- Market Overview
- NS1 Antigen Tests
- IgM and IgG Serology ELISA
- RT-PCR Molecular Tests
- Combination and Panel Assays
- Novel Biosensor-Based Tests
Global Dengue Testing Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Rapid Diagnostic Test Kits
- ELISA Kits and Reagents
- PCR Molecular Assay Kits
Global Dengue Testing Market Size by Sample Type & CAGR (2026-2033)
- Market Overview
- Serum and Plasma
- Whole Blood
- Finger-Stick
- Venous Blood
- Saliva and Oral Fluid
- Others
Global Dengue Testing Market Size by Service Modality & CAGR (2026-2033)
- Market Overview
- Centralized Laboratory Testing
- Point-of-Care Testing
Global Dengue Testing Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care and Self-Testing Centres
- Public Health and Surveillance Agencies
- Others
Global Dengue Testing Market Size & CAGR (2026-2033)
- North America (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
- US
- Canada
- Europe (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Diagnostic Technology, Product Type, Sample Type, Service Modality, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Standard Diagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ortho Clinical Diagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nova Biologicals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QuidelOrtho Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Artron Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CTK Biotech Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- InBios International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GeneReach Biotechnology Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SD Biosensor Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
